YouTubeFacebookLinkedInTwitterinstagramrss

The lab of the future: Unrealistic utopia or achievable goal?


(March 12, 2015)

 

Sponsored by
IDBS logo
 

Does the idea of the lab of the future conjure up images of endless cost and resources diverted to new and complex systems? Does mobility feel like a Pandora’s box? You may be severely overestimating TCO and going down the wrong route to modernizing your processes.

Join us on March 12 to look past the catchy labels and explore what tomorrow’s lab should really be about: combatting complexity and making smart choices for managing data. We’ll be taking a look at the real drivers changing the nature of research and development (R&D) and their knock-on effects on R&D enterprise software. Explore the most efficient and cost effective ways ELNs can help you collaborate, get your products to market quicker and gain greater insight from your data.

Learning Objectives:

  • Mobility – How to stay clear of the mobility bandwagon and making the right choices about which lab processes to make mobile friendly.
  • Cost and speed to market – Learn how a single, secure platform for managing R&D data that’s flexible and scalable can save you time and money and help you get your products to market quicker and more efficiently.
  • Adapting to your needs - Whether you’re going paperless for the first time or moving into web-enabled working, it’s a chance to map out your processes and make improvements.

Speaker:


Scott WeissDr Scott Weiss, Senior Director of Product Management, IDBS

Scott joined IDBS in 2004, and leverages over 25 years’ experience in pharmaceutical drug development, informatics and software development. He is currently responsible for product strategy at IDBS, and enjoys leading a talented team focused on designing intuitive software that enables organizations to accelerate their R&D - by fostering efficiency, collaboration and data insight.

Prior to IDBS, he served as Director of In-Vivo Pharmacology at Vernalis Research. Scott obtained his PhD in Psychology specializing in neuroscience at the University of Leeds and has authored over 45 scientific papers, journal articles and patents.